Hydroxysteroid (17β) dehydrogenase X in human health and disease

Molecular and Cellular Endocrinology

Volumn 343, Issue 1-2, 2011, Pages 1-6

  Yang, Song Yu ^a   He, Xue Ying ^a   Miller, David ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer disease; Down's syndrome; HSD10 deficiency; Mitochondria; MRXS10; Multifunctional enzyme

Indexed keywords

HYDROXYSTEROID 17BETA DEHYDROGENASE 10; HYDROXYSTEROID DEHYDROGENASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CATALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN SYNDROME; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE; HSD17B10 GENE; HUMAN; MENTAL RETARDATION X LINKED ABNORMAL BEHAVIOR; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; X CHROMOSOME LINKED DISORDER;

3-HYDROXYACYL COA DEHYDROGENASES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CATALYTIC DOMAIN; DOWN SYNDROME; HUMANS; MENTAL RETARDATION, X-LINKED; MITOCHONDRIA; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTATION, MISSENSE; NEURODEGENERATIVE DISEASES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN SUBUNITS; STEROIDS;

EID: 80051572799     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.011     Document Type: Review

References (55)

1. Cheon M.S., Dierssen M., Kim S.H., Lubec G. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 2008, 35:339-343.
2. Ensenauer R., Niederhoff H., Ruiter J.P., Wanders R.J., Schwab K.O., Brandis M., Lehnert W. Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency. Annals of Neurology 2002, 51:656-659.
3. Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O., Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H., Chelly J., Sanlaville D., van Bokhoven H., Ropers H.H., Laumonnier F., Ranieri E., Schwartz C.E., Abidi F., Tarpey P.S., Futreal P.A., Whibley A., Raymond F.L., Stratton M.R., Fryns J.P., Scott R., Peippo M., Sipponen M., Partington M., Mowat D., Field M., Hackett A., Marynen P., Turner G., Gécz J. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. American Journal of Human Genetics 2008, 82:432-443.
4. García-Villoria J., Navarro-Sastre A., Fons C., Pérez-Cerdá C., Baldellou A., Fuentes-Castelló M.A., González I., Hernández-Gonzalez A., Fernández C., Campistol J., Delpiccolo C., Cortés N., Messeguer A., Briones P., Ribes A. Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis. Clinical Biochemistry 2009, 1-2:27-33.
5. Garcia-Villoria J., Gort L., Madrigal I., Fons C., Fernandez C., Navarro-Sastre A., Milà M., Briones P., García-Cazorla A., Campistol J., Ribes A. X-inactivation of HSD17B10 revealed by cDNA analysis in two female patients with 17β-hydroxysteoid dehydrogenase 10 deficiency. European Journal of Human Genetics 2010, 18:1353-1355.
6. He X.-Y., Yang S.-Y. Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids. Endocrine, Metabolic & Immune Disorders: Drug Targets 2006, 6:95-102.
7. He X.-Y., Yang S.-Y. Comments on 'Significance of developmental expression of amphioxus Branchiostoma belcheri and zebrafish Danio rerio Hsd17b10 In biological and medical research'. Journal of Fish Biology 2009, 74:1689-1692.
8. He X.-Y., Schulz H., Yang S.-Y. A human brain L-3-hydroxyacyl coenzyme A dehydrogenase is identical with an amyloid β-peptide binding protein involved in Alzheimer's disease. Journal of Biological Chemistry 1998, 273:10741-10746.
9. He X.-Y., Merz G., Mehta P., Schulz H., Yang S.-Y. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17β-hydroxysteroid dehydrogenase. Journal of Biological Chemistry 1999, 274:15014-15019.
10. He X.-Y., Yang Y.-Z., Schulz H., Yang S.-Y. Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short chain l-3-hydroxyacyl-CoA dehydrogenase. Biochemical Journal 2000, 345:139-143.
11. He X.-Y., Merz G., Yang Y.-Z., Pullarkat R., Mehta P., Schulz H., Yang S.-Y. Function of human short chain L-3-hydroxyacyl-CoA dehydrogenase in androgen metabolism. Biochimica et Biophysica Acta 2000, 1484:267-277.
12. He X.-Y., Merz G., Yang Y.-Z., Mehta P., Schulz H., Yansg S.-Y. Characterization and localization of human type 10 17beta-hydroxysteroid dehydrogenase. European Journal of Biochemistry 2001, 268:4899-4907.
13. He X.-Y., Merz G., Chu C.-H., Lin D., Yang Y.-Z., Mehta P., Schulz H., Yang S.-Y. Molecular cloning, modeling, and localization of rat type 10 17β-hydroxysteroid dehydrogenase. Molecular and Cellular Endocrinology 2001, 171:89-98.
14. He X.-Y., Wen G.-Y., Merz G., Lin D., Yang Y.-Z., Mehta P., Schulz H., Yang S.-Y. Abundant short chain L-3-hydroxyacyl-CoA dehydrogenase/type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Molecular Brain Research 2002, 99:46-53.
15. He X.-Y., Yang Y.-Z., Peehl D.M., Lauderdale A., Schulz H., Yang S.-Y. Oxidation 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase. Journal of Steroid Biochemistry and Molecular Biology 2003, 87:191-198.
16. He X.-Y., Wegiel J., Yang S.-Y. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase. Brain Research 2005, 1040:29-35.
17. He X.-Y., Wegiel J., Yang Y.-Z., Pullarkat R., Schulz H., Yang S.-Y. Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors. Molecular and Cellular Endocrinology 2005, 229:111-117.
18. He X.-Y., Dobkin C., Yang S.Y. Does the HSD17B10 gene escape from X-inactivation?. European Journal of Human Genetics 2011, 19:123-124.
19. Holzmann J., Frank P., Löffler E., Bennett K.L., Gerner C., Rossmanith W. RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme. Cell 2008, 135:462-474.
20. Hovorkova P., Kristofikova Z., Horinek A., Ripova D., Majer E., Zach P., Sellinger P., Ricny J. Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people. Dementias Geriatric Cognition Disorder 2008, 26:193-198.
21. Jazbutyte V., Kehl F., Neyses L., Pelzer T. Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. Biochemical and Biophysical Research Communications 2009, 384:450-454.
22. Jenkins E.C., Velinov M.T., Ye L., Gu H., Li S., Jenkins E.C., Brooks S.S., Pang D., Devenny D.A., Zigman W.B., Schupf N., Silverman W.P. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiology of Aging 2006, 27:941-945.
23. Korenberg J.R., Kawashima H., Pulst S.-M., Ikeuchi T., Ogasawara N., Yamamoto K., Schonberg S.A., West R., Allen L., Magenis E., Ikawa K., Taniguchi N., Epstein C.J. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. American Journal of Human Genetics 1990, 47:236-246.
24. Korman S.H., Yang S.-Y. HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydoxybutyryl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism 2007, 91:115.
25. Koshland D.E. Crazy, but correct. Nature 2004, 432:447.
26. Kristofikova Z., Bockova M., Hegnerova K., Bartos A., Klaschka J., Rícný J., Rípová D., Homola J. Enhanced levels of mitochondrial enzyme 17 beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis. Molecular BioSystems 2009, 5:1174-1179.
27. Lenski C., Kooy R.F., Reyniers E., Loessner D., Wanders R.J.A., Winnepenninckx B., Hellebrand H., Engert S., Schwartz C.E., Meindl A., Ramser J. The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior. American Journal of Human Genetics 2007, 80:372-377.
28. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304:448-452.
29. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., Reddy P.H. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Human Molecular Genetics 2006, 15:1437-1449.
30. Marques A.T., Antunes A., Fernandes P.A., Ramos M.J. Comparative evolutionary genomics of the HADH2 gene encoding Aβ binding alcohol dehydrogenase/17β-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10). BMC Genomics 2006, 7:202-221.
31. Moeller G., Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenase. Molecular and Cellular Endocrinology 2009, 301:7-19.
32. Muirhead K.E., Froemming M., Li X., Musilek K., Conway S.J., Sames D., Gunn-Moore F.J. (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells. ACS Chemical Biology 2010, 5:1105-1114.
33. Murakami Y., Ohsawa I., Kasahara T., Ohta S. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiology of Aging 2009, 30:325-329.
34. Ofman R., Ruiter J.P.N., Feenstra M., Duran M., Poll-The B.T., Zschocke J., Ensenauer R., Lehnert W., Sass J.O., Sperl W., Wanders R.J. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. American Journal of Human Genetics 2003, 72:1300-1307.
35. Oppermann U.C., Salim S., Tjernberg L.O., Terenius L., Jornvall H. Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implication for apoptosis in Alzheimer's disease. FEBS Letters 1999, 451:238-242.
36. Perez-Cerda C., García-Villoria J., Ofman R., Sala P.R., Merinero B., Ramos J., García-Silva M.T., Beseler B., Dalmau J., Wanders R.J., Ugarte M., Ribes A. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease. Pediatric Research 2005, 58:488-491.
37. Rauschenberger K., Scholer K., Sass J.O., Sauver S., Djuric Z., Rumig C., Wolf N.I., Okun J.G., Kölker S., Schwarz H., Fischer C., Grziwa B., Runz H., Nümann A., Shafqat N., Kavanagh K.L., Hämmerling G., Wanders R.J., Shield J.P., Wendel U., Stern D., Nawroth P., Hoffmann G.F., Bartram C.R., Arnold B., Bierhaus A., Oppermann U., Steinbeisser H., Zschocke J. A non-enzymatic function of 17β-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival. EMBO Molecular Medicine 2010, 2:1-12.
38. Reyniers E., Van Bogaert P., Peeters N., Vits L., Pauly F., Fransen E., Van Regemorter N., Kooy R.F. A new neurological syndrome with mental retardation, choreoathetosis, and abnormal behavior maps to chromosome Xp11. American Journal of Human Genetics 1999, 65:1406-1412.
39. Salas S., Jézéquel P., Campion L., Deville J.L., Chibon F., Bartoli C., Gentet J.C., Charbonnel C., Gouraud W., Voutsinos-Porche B., Brouchet A., Duffaud F., Figarella-Branger D., Bouvier C. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2. International Journal of Cancer 2009, 125:851-860.
40. Sambamurti K., Greig N.H., Utsuki T., Barnwell E., Sharma M., Cheryl N.R., Kindy M.S., Lahiri D.K., Pappolla M.A. Targets for AD treatment: conflicting messages from γ-secretase inhibitors. Journal of Neurochemistry 2011, 117:359-374.
41. Santos R.X., Correia S.C., Wang X., Perry G., Smith M.A., Moreira P.L., Zhu X. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. International Journal Clinical Experimental Pathology 2010, 3:570-581.
42. Seaver, L.H., He, X.-Y., Abe, K., Cowan, T., Enns, G.M., Sweetman, L., Philipp, M., Lee, S., Malik, M., Yang, S.-Y., submitted for publication. A novel mutation in the HSD17B10 gene of a 10-years boy with refractory epilepsy, choreoathetodsis and learning disability.
43. Selko D.J. Alzheimer's disease: genes, proteins, and therapy. Physiological Reviews 2001, 81:741-766.
44. Shafqat N., Marschall H., Filling C., Nordling E., Wu X.-Q., Bjork L., Thyberg J., Martensson E., Salim S., Jornvall H., Oppermann U. Expended substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenase reveal multiple specificities in bile acid and steroid hormone metabolism. Characterization of multifunctional 3α/7α/7β/20β/21-hydroxysteroid dehydrogenase. Biochemical Journal 2003, 376:49-60.
45. Xu H., Wang R., Zhang Y.W., Zhang X. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Annals of the New York Academy of Sciences 2006, 1089:324-342.
46. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu E., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 1997, 89:689-695.
47. Yan S.D., Shi Y., Zhu A., Fu J., Zhu H., Zhu Y., Gibson L., Stern E., Colison K., Al-Mohanna F., Ogawa S., Roher A., Clarke S.G., Stern D.M. Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta- induced cytotoxicity. Journal of Biological Chemistry 1999, 274:2145-2156.
48. Yan S.D., Zhu Y., Stern E.D., Hwang Y.C., Hori O., Ogawa S., Frosch M.P., Conolly E.S., McTaggert R., Pinsky D.J., Clarke S., Stern D.M., Ramasamy R. Amyloid β-peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. Journal of Biological Chemistry 2000, 275:27100-27109.
49. Yang S.-Y., He X.-Y. Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease. Neuropathology and Genetics of Dementia 2001, 101-110. Kluwer Academic, New York. M. Tolnay, A. Probst (Eds.).
50. Yang S.-Y., He X.-Y., Schulz H. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Trends in Endocrinology and Metabolism 2005, 16:167-175.
51. Yang S.-Y., He X.-Y., Schulz H. 3-Hydroxyacyl-CoA dehydrogenase and short-chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease. FEBS Journal 2005, 272:4874-4883.
52. Yang S.-Y., He X.-Y., Miller D. HSD17B10: agene involved in cognitive function through metabolism of Isoleucine and neuroactive steroids. Molecular Genetics and Metabolism 2007, 92:36-42.
53. Yang S.-Y., He X.-Y., Olpin S.E., Sutton V.R., McMenamin J., Philipp M., Denman R.B., Malik M. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14820-14824.
54. Zschocke J., Ruiter J.P., Brand J., Lindner M., Hoffmann G.F., Wanders R.J., Mayatepek E. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatric Research 2000, 48:852-855.
55. Windholz M. The Merk Index 1988, Merck & Co., Inc., New Jersy. 10 ed.